0G5I Stock Overview
Develops diagnostic systems used in point of care testing in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Prolight Diagnostics AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.46 |
| 52 Week High | SEK 0.46 |
| 52 Week Low | SEK 0.31 |
| Beta | 2.25 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -92.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0G5I | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | -1.7% | -1.4% |
| 1Y | n/a | -9.4% | 6.4% |
Return vs Industry: Insufficient data to determine how 0G5I performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how 0G5I performed against the UK Market.
Price Volatility
| 0G5I volatility | |
|---|---|
| 0G5I Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.9% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.9% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0G5I has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0G5I's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | n/a | Ulf Bladin | prolightdiagnostics.se |
Prolight Diagnostics AB (publ) develops diagnostic systems used in point of care testing in Sweden. It engages in the development of PLD micro flex consisting of test cards and mobile instrument for analysis of the biomarkers in the current test; and flex membrane. Prolight Diagnostics AB (publ) was founded in 1999 and is based in Stockholm, Sweden.
Prolight Diagnostics AB (publ) Fundamentals Summary
| 0G5I fundamental statistics | |
|---|---|
| Market cap | SEK 266.46m |
| Earnings (TTM) | -SEK 17.22m |
| Revenue (TTM) | SEK 11.14m |
23.9x
P/S Ratio-15.5x
P/E RatioIs 0G5I overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0G5I income statement (TTM) | |
|---|---|
| Revenue | SEK 11.14m |
| Cost of Revenue | SEK 0 |
| Gross Profit | SEK 11.14m |
| Other Expenses | SEK 28.36m |
| Earnings | -SEK 17.22m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.061 |
| Gross Margin | 100.00% |
| Net Profit Margin | -154.63% |
| Debt/Equity Ratio | 0% |
How did 0G5I perform over the long term?
See historical performance and comparison